These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36613622)

  • 21. N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity.
    Dietrich A; Mederos y Schnitzler M; Emmel J; Kalwa H; Hofmann T; Gudermann T
    J Biol Chem; 2003 Nov; 278(48):47842-52. PubMed ID: 12970363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial TRPC3 promotes cell proliferation by regulating the mitochondrial calcium and metabolism in renal polycystin-2 knockdown cells.
    Li Z; Zhou J; Li Y; Yang F; Lian X; Liu W
    Int Urol Nephrol; 2019 Jun; 51(6):1059-1070. PubMed ID: 31012036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing.
    Sexton JE; Desmonds T; Quick K; Taylor R; Abramowitz J; Forge A; Kros CJ; Birnbaumer L; Wood JN
    Neurosci Lett; 2016 Jan; 610():36-42. PubMed ID: 26520460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of Transient Receptor Potential Channels 3 and 6 Regulates Osteoclast Function with Impact on Trabecular Bone Loss.
    Klein S; Mentrup B; Timmen M; Sherwood J; Lindemann O; Fobker M; Kronenberg D; Pap T; Raschke MJ; Stange R
    Calcif Tissue Int; 2020 Jun; 106(6):655-664. PubMed ID: 32140760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of Transient Receptor Potential Canonical Channel Activators Identifies Novel Neurotrophic Piperazine Compounds.
    Sawamura S; Hatano M; Takada Y; Hino K; Kawamura T; Tanikawa J; Nakagawa H; Hase H; Nakao A; Hirano M; Rotrattanadumrong R; Kiyonaka S; Mori MX; Nishida M; Hu Y; Inoue R; Nagata R; Mori Y
    Mol Pharmacol; 2016 Mar; 89(3):348-63. PubMed ID: 26733543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.
    Pablo JL; Greka A
    Trends Pharmacol Sci; 2019 Dec; 40(12):911-918. PubMed ID: 31704171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels.
    Harteneck C; Gollasch M
    Curr Pharm Biotechnol; 2011 Jan; 12(1):35-41. PubMed ID: 20932261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation and Diverse Roles of TRPC3 and TRPC6 in Synaptic Reorganization of the Mossy Fiber Pathway in Temporal Lobe Epilepsy.
    Zeng C; Zhou P; Jiang T; Yuan C; Ma Y; Feng L; Liu R; Tang W; Long X; Xiao B; Tian F
    Mol Neurobiol; 2015 Aug; 52(1):562-72. PubMed ID: 25213992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Function and regulation of endothelin type A receptor-operated transient receptor potential canonical channels.
    Horinouchi T; Terada K; Higa T; Aoyagi H; Nishiya T; Suzuki H; Miwa S
    J Pharmacol Sci; 2011; 117(4):295-306. PubMed ID: 22129540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystins: polymodal receptor/ion-channel cellular sensors.
    Delmas P
    Pflugers Arch; 2005 Oct; 451(1):264-76. PubMed ID: 15889307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone.
    Loga F; Domes K; Freichel M; Flockerzi V; Dietrich A; Birnbaumer L; Hofmann F; Wegener JW
    Cardiovasc Res; 2013 Nov; 100(2):280-7. PubMed ID: 23832809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the receptor-activated human TRPC6 and TRPC3 ion channels.
    Tang Q; Guo W; Zheng L; Wu JX; Liu M; Zhou X; Zhang X; Chen L
    Cell Res; 2018 Jul; 28(7):746-755. PubMed ID: 29700422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRPC6 and kidney disease: sclerosing more than just glomeruli?
    Schlondorff J
    Kidney Int; 2017 Apr; 91(4):773-775. PubMed ID: 28314576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains.
    Kunert-Keil C; Bisping F; Krüger J; Brinkmeier H
    BMC Genomics; 2006 Jun; 7():159. PubMed ID: 16787531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line.
    Thebault S; Zholos A; Enfissi A; Slomianny C; Dewailly E; Roudbaraki M; Parys J; Prevarskaya N
    J Cell Physiol; 2005 Jul; 204(1):320-8. PubMed ID: 15672411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of endogenous TRPC6 channels in Ca2+ signal generation in A7r5 smooth muscle cells.
    Soboloff J; Spassova M; Xu W; He LP; Cuesta N; Gill DL
    J Biol Chem; 2005 Dec; 280(48):39786-94. PubMed ID: 16204251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.
    Zeng B; Yuan C; Yang X; Atkin SL; Xu SZ
    Curr Cancer Drug Targets; 2013 Jan; 13(1):103-16. PubMed ID: 22920441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRPC3/6/7: Topical aspects of biophysics and pathophysiology.
    Eder P; Groschner K
    Channels (Austin); 2008; 2(2):94-9. PubMed ID: 18849655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels.
    Qu C; Ding M; Zhu Y; Lu Y; Du J; Miller M; Tian J; Zhu J; Xu J; Wen M; Er-Bu A; Wang J; Xiao Y; Wu M; McManus OB; Li M; Wu J; Luo HR; Cao Z; Shen B; Wang H; Zhu MX; Hong X
    J Med Chem; 2017 Jun; 60(11):4680-4692. PubMed ID: 28395140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.